Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1351267

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department have taken steps to enable people who participated in the Novavax covid-19 vaccine trials to travel internationally; and what support his Department has provided to the European Medicines Agency for the registration of that vaccine.
tabling member constituency	Henley
tabling member printed	John Howell
uin	40817
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Government continues to make the case that anyone on a COVID-19 vaccine trial should be treated the same in terms of certification as someone who has received a deployed vaccine. Our Chief Medical Officer has written to all of his counterparts in the European Union and European Economic Community on this matter. Discussions are ongoing with other countries, including through groups such as the Group of Seven, the European Commission and the World Health Organisation to shape the approach taken around the world to sharing health status for travel.</p><p>The Vaccines Taskforce and the Medicines and Healthcare products Regulatory Agency (MHRA) are working with Novavax to help ensure their COVID-19 vaccine is authorised as quickly as possible. The decision to license a vaccine is made by the MHRA.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 41230 question first answered 06/09/2021 11:43:29 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1606 label Biography information for John Howell

1349236

registered interest
date	21/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of collecting data on the (a) number of people who have contracted covid-19 after receiving two doses of a vaccine and (b) average length of stay for those double-vaccinated people who have been admitted to hospital.
tabling member constituency	Henley
tabling member printed	John Howell
uin	37418
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Public Health England monitors the number of people who have tested positive for COVID-19 and whether they have received one or two doses of the vaccination. This data is used to calculate vaccine effectiveness estimates which are available at the following link:</p><p><a href="https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-report" target="_blank">https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-report</a></p><p>NHS Digital collects data on the number of people who have contracted COVID-19, patients who have received one or two doses of a vaccine and hospital data that can be used to calculate average length of stay. These three datasets can be linked where possible to track patient outcomes for vaccinated people.</p><p> </p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:18:46 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1606 label Biography information for John Howell